ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(45 sites)

United States

Research Site, Los Angeles, California

Research Site, Torrance, California

Research Site, Aurora, Colorado

Research Site, Boston, Massachusetts

Research Site, Ann Arbor, Michigan

Research Site, Las Vegas, Nevada

Research Site, New York, New York

Research Site, Portland, Oregon

Argentina

Research Site, CABA

Research Site, Ciudad de Buenos Aires

Brazil

Research Site, Curitiba

Research Site, Ribeirão Preto

Research Site, Rio de Janeiro

Research Site, São Paulo

China

Research Site, Beijing

Research Site, Guangzhou

Research Site, Kunming

Research Site, Shanghai

Denmark

Research Site, Copenhagen

Research Site, Odense

Hungary

Research Site, Budapest

Research Site, Pécs

Research Site, Szeged

Italy

Research Site, Cona

Research Site, Genoa

Research Site, Messina

Research Site, Milan

Research Site, Naples

Research Site, Pisa

Research Site, Roma

Lithuania

Research Site, Kaunas

Research Site, Vilnius

Netherlands

Research Site, Leiden

Research Site, Rotterdam

Poland

Research Site, Bydgoszcz

Research Site, Gliwice

Research Site, Krakow

Research Site, Warsaw

Research Site, Wroclaw

Romania

Research Site, Bucharest

Research Site, Cluj-Napoca